Spyre Therapeutics, Inc. — Form 4
Filed July 2, 2026 · analyzed by the Insider Agent
4
▼ Likely negative
significance 44/100
What the filing says
Chief Executive Officer Turtle Cameron (SYRE) sold 15K shares (~$1.3M) on the open market (2.5% of holdings). Open-market sale — often routine.
Why this rating
Open-market sale — often routine.
View original filing on SEC.gov ↗
See more from July 2, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.